USD 36.1 billion
Antiviral Drugs Market Size, Share, Growth Analysis, By Type(Branded Drugs and Generic Drugs.), By Application(HIV/AIDS, Hepatitis, Influenza, Herpes and Other Indications.), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35B2171 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
62
|Figures:
75
Antiviral Drugs Market Insights
Antiviral Drugs Market size was valued at USD 36.1 billion in 2021 and is poised to grow from USD 37.26 billion in 2022 to USD 47.93 billion by 2030, growing at a CAGR of 3.2% during the forecast period (2023-2030).
The global antiviral drugs market is experiencing substantial growth due to several key factors. Firstly, the increasing incidence of viral infections, particularly HIV/AIDS, hepatitis B and C, and influenza, has created a significant demand for effective antiviral therapies. Pharmaceutical companies are investing in research and development activities to develop novel antiviral drugs with enhanced efficacy, reduced side effects, and improved patient compliance. The discovery of new drug targets and the development of innovative therapeutic approaches have expanded the range of treatment options available to healthcare professionals. Additionally, the growing awareness about viral infections and the importance of early diagnosis and treatment has fueled the demand for antiviral drugs. Governments and healthcare organizations worldwide are increasingly focusing on prevention and control measures to reduce the burden of viral diseases, which has further boosted the market. Moreover, favorable government initiatives and funding for research and development activities in the field of antiviral drugs have stimulated market growth. Public-private partnerships and collaborations have played a crucial role in advancing antiviral drug discovery and ensuring their accessibility and affordability.
Lastly, the rising investment by pharmaceutical companies in the development of antiviral drugs, coupled with the increasing number of clinical trials, has significantly contributed to market expansion. These companies are investing in research and development to address the unmet medical needs associated with viral infections and to capitalize on the market potential. Overall, the global market is witnessing steady growth, driven by the increasing prevalence of viral infections, advancements in medical research, growing awareness, government initiatives, and pharmaceutical investments.
US Antiviral Drugs Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Branded Drugs
Fastest Growth
Growth Rate
3.2% CAGR
Global Antiviral Drugs Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Antiviral Drugs Market Segmental Analysis
The Global Antiviral Drugs Market is segmented by type, application, and region. Based on type, the market can be segmented into Branded Drugs and Generic Drugs. Based on application, the market is segmented into HIV/AIDS, Hepatitis, Influenza, Herpes and Other Indications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Antiviral Drugs Market Analysis by Type
Among branded drugs and generic drugs in the global antiviral drugs market, the dominant type is branded drugs. Branded drugs are pharmaceutical products that are marketed under a specific brand name by the original manufacturer. These drugs often have patent protection, allowing the manufacturer to exclusively sell and distribute them for a certain period, thereby establishing a strong market presence.
On the other hand, the fastest-growing type in the global antiviral drugs market is generic drugs. Generic drugs are bioequivalent versions of branded drugs that become available after the patent protection of the original drug expires. Generic drugs contain the same active ingredients as their branded counterparts and are typically sold at a lower price. They undergo rigorous regulatory evaluation to ensure their safety, efficacy, and quality.
Antiviral Drugs Market Analysis by Application
The HIV/AIDS segment holds a significant market share and remains the dominant application in the global antiviral drugs market. HIV (Human Immunodeficiency Virus) is a global health concern, and the development of antiviral drugs has revolutionized the treatment and management of HIV/AIDS. Antiretroviral therapy (ART) plays a vital role in suppressing viral replication, slowing disease progression, and improving the quality of life for individuals living with HIV/AIDS. The prevalence of HIV/AIDS and the continuous research and development efforts in this field contribute to the dominance of the HIV/AIDS segment.
However, the Hepatitis segment is witnessing the fastest growth in the global antiviral drugs market. Hepatitis, particularly Hepatitis B and Hepatitis C, represents a significant healthcare burden worldwide. Antiviral drugs for Hepatitis aim to inhibit viral replication, prevent liver damage, and reduce the risk of complications such as cirrhosis and liver cancer. The growing awareness about the availability of effective antiviral treatments, increased screening and diagnosis efforts, and advancements in therapeutic options have fueled the growth of the Hepatitis segment. Additionally, initiatives for the elimination of viral Hepatitis and the development of new direct-acting antiviral (DAA) drugs have further accelerated the market growth for Hepatitis antiviral drugs.
Global Antiviral Drugs Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Antiviral Drugs Market Regional Insights
North America holds a significant share in the antiviral drugs market due to several factors. The region has a well-established healthcare infrastructure, advanced research and development capabilities, and a high prevalence of viral infections such as HIV/AIDS, hepatitis, and influenza. Additionally, the presence of key market players and pharmaceutical companies in North America contributes to the dominant position of the region. The availability of healthcare facilities, favorable reimbursement policies, and robust regulatory frameworks further support the market growth in this region.
On the other hand, the Asia Pacific region is experiencing rapid growth in the antiviral drugs market. Factors such as a large population base, increasing awareness about viral infections, and rising healthcare expenditure are driving the market growth in this region. The Asia Pacific region has witnessed significant advancements in healthcare infrastructure, access to medical services, and a growing emphasis on disease prevention and management.
Global Antiviral Drugs By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Antiviral Drugs Market Dynamics
Antiviral Drugs Market Drivers
High Demand for Antiretroviral Therapy
- The global prevalence of HIV/AIDS has created a substantial market demand for antiretroviral therapy. The introduction of highly active antiretroviral therapy (HAART) has revolutionized the management of HIV/AIDS, improving the life expectancy of infected individuals and driving the growth of the antiviral drugs market.
Antiviral Drugs Market Restraints
Stringent Regulatory Frameworks
- The regulatory approval processes for antiviral drugs are stringent and time-consuming. Meeting the rigorous requirements for safety, efficacy, and quality standards can lead to significant delays in market entry for new drugs. Strict regulations pose challenges for manufacturers and may hinder the timely availability of effective antiviral treatments. Compliance with these regulatory frameworks is crucial but can prolong the drug development and approval timelines.
Request Free Customization of this report to help us to meet your business objectives.
Antiviral Drugs Market Competitive Landscape
The competitive landscape of the global antiviral drugs market is characterized by the presence of numerous pharmaceutical and biotechnology companies engaged in research, development, and commercialization of antiviral medications. These companies strive to gain a competitive edge by investing heavily in research and development activities to discover and develop novel antiviral drugs. They also focus on enhancing existing antiviral therapies to improve efficacy, minimize side effects, and overcome drug resistance.
Antiviral Drugs Market Top Player’s Company Profiles
- Gilead Sciences Inc. (US)
- Roche Holding AG (Switzerland)
- Johnson & Johnson (US)
- Merck & Co., Inc. (US)
- AbbVie Inc. (US)
- Bristol Myers Squibb (US)
- GlaxoSmithKline plc (UK)
- Pfizer Inc. (US)
- Novartis AG (Switzerland)
- AstraZeneca PLC (UK)
- Eli Lilly and Company (US)
- Takeda Pharmaceutical Company Limited (Japan)
- Boehringer Ingelheim GmbH (Germany)
- Biogen Inc. (US)
- Sanofi (France)
- Moderna, Inc. (US)
- Cipla Limited (India)
- Sun Pharmaceutical Industries Ltd. (India)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
Antiviral Drugs Market Recent Developments
- In March 2023, Gilead Sciences announced the launch of its new antiviral drug, called Veklury. Veklury is a treatment for COVID-19 and is said to be effective against the Omicron variant.
- In February 2023, Merck announced the launch of its new antiviral drug, called Molnupiravir. Molnupiravir is a treatment for COVID-19 and is said to be effective against the Delta variant.
- In January 2023, Pfizer announced the launch of its new antiviral drug, called Paxlovid. Paxlovid is a treatment for COVID-19 and is said to be effective against the Omicron variant.
- In December 2022, AbbVie announced the launch of its new antiviral drug, called Mavyret. Mavyret is a treatment for hepatitis C and is said to be more effective than older treatments.
- In November 2022, Bristol Myers Squibb announced the launch of its new antiviral drug, called Zepatier. Zepatier is a treatment for hepatitis C and is said to be more effective than older treatments.
Antiviral Drugs Key Market Trends
- Increasing focus on the development of broad-spectrum antiviral drugs: Broad-spectrum antivirals are medications that can effectively target and inhibit multiple viruses, regardless of their specific strains or types. This trend stems from the need for effective treatment options against emerging viral infections and the challenges associated with developing specific antiviral drugs for each individual virus. Broad-spectrum antivirals offer advantages in terms of cost-effectiveness, rapid response to viral outbreaks, and improved patient outcomes by providing a broader coverage against multiple viral pathogens. The development of broad-spectrum antiviral drugs is driven by advancements in drug discovery and innovative research approaches, including targeting viral host factors and employing broad-spectrum antiviral mechanisms.
Antiviral Drugs Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to the Global Antiviral Drugs Market analysis, the increasing prevalence of viral infections worldwide is a key driver for the growth of the antiviral drugs market. Factors such as globalization, population growth, and the emergence of new viral strains contribute to the rising incidence of viral diseases. The COVID-19 pandemic has further underscored the need for effective antiviral drugs, triggering extensive research and development efforts in this field. Pharmaceutical companies are investing heavily in research to discover new antiviral compounds and improve existing drug formulations. The introduction of innovative delivery systems, such as long-acting injectables and nanotechnology-based drug delivery, enhances the efficacy and patient compliance of antiviral therapies. Diseases such as HIV, hepatitis B and C, and herpes viruses require long-term antiviral therapy to manage the infection and prevent disease progression. The increasing awareness about early diagnosis and treatment initiation, along with the availability of combination drug regimens, is driving the demand for antiviral drugs in the management of chronic viral infections. However, the market analysis also identifies certain challenges and restraints that may impede market growth. Stringent regulatory guidelines, high development costs, and the potential for drug resistance are some of the factors that pose challenges to antiviral drug development and commercialization. Additionally, the availability of generic antiviral drugs and the presence of alternative treatment options may limit the revenue potential for certain market players.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 36.1 billion |
| Market size value in 2031 | USD 47.93 billion |
| Growth Rate | 3.2% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Antiviral Drugs Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Antiviral Drugs Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Antiviral Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Antiviral Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Antiviral Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Antiviral Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
